FY2023 (April 1, 2022 - March 31, 2023)

(Millions of Yen)
Takara Holdings
Inc.
(Consolidated)
y-o-
y(%)
Takara
Shuzo
y-o-
y(%)
Takara
Shuzo
International
Group
y-o-
y(%)
Takara
Bio
Group
y-o-
y(%)
Sales to customer 350,665 116.5% 122,921 102.7% 137,483 134.5% 78,142 115.4%
Cost of sales 230,723 123.1% 93,645 103.0% 95,088 135.8% 33,377 180.5%
Gross profit 119,941 105.6% 29,276 101.6% 42,394 131.9% 44,765 91.0%
SG&A expenses 81,996 116.8% 24,385 98.8% 31,573 133.4% 24,224 119.3%
Operating income 37,945 87.5% 4,890 118.3% 10,821 127.7% 20,541 71.1%
Non-operating
income
1,678 112.5% 544 193.3% 315 106.1% 363 101.5%
Non-operating
expenses
917 56.8% 567 163.6% 169 54.8% 221 27.7%
Ordinary income 38,706 89.5% 4,867 119.6% 10,967 129.6% 20,682 72.7%
Extraordinary gain 1,681 36.1% 63 56.9% 8 283.1% 930 20.8%
Extraordinary loss 694 10.0% 234 17.8% 68 33.8% 388 7.2%
Income before
income taxes and
minority interests
39,692 96.9% 4,696 164.2% 10,907 132.0% 21,224 77.1%
Net income
attributable to
owners of the parent
21,206 102.1% 3,237 166.2% 6,434 119.9% 16,012 80.7%
―――― ―――― ―――― ―――― ―――― ―――― ―――― ―――― ――――
Research and
development
expenses
8,949 138.0% 367 100.3% 0 - 8,575 140.4%
Capital
expenditures
14,165 87.4% 2,763 154.8% 4,704 557.4% 6,516 49.4%
Depreciation 9,118 108.2% 2,467 95.3% 2,043 122.0% 4,050 113.9%
Amortization of
goodwill
998 114.1% 0 - 399 106.5% 599 119.8%